BridgeBio Pharma, Inc. (BBIO)

BridgeBio Pharma Statistics

Total Valuation

BBIO has a market cap or net worth of $6.39 billion. The enterprise value is $7.85 billion.

Market Cap	6.39B
Enterprise Value	7.85B

Important Dates

The next estimated earnings date is Thursday, February 20, 2025, before market open.

Earnings Date	Feb 20, 2025
Ex-Dividend Date	n/a

Share Statistics

BBIO has 188.99 million shares outstanding. The number of shares has increased by 16.50% in one year.

Current Share Class	188.99M
Shares Outstanding	188.99M
Shares Change (YoY)	+16.50%
Shares Change (QoQ)	+0.49%
Owned by Insiders (%)	5.47%
Owned by Institutions (%)	65.74%
Float	128.27M

Valuation Ratios

PE Ratio	n/a
Forward PE	n/a
PS Ratio	28.29
Forward PS	55.56
PB Ratio	n/a
P/TBV Ratio	n/a
P/FCF Ratio	n/a
P/OCF Ratio	n/a
PEG Ratio	n/a

Enterprise Valuation

EV / Earnings	n/a
EV / Sales	36.05
EV / EBITDA	n/a
EV / EBIT	n/a
EV / FCF	n/a

Financial Position

The company has a current ratio of 3.19

Current Ratio	3.19
Quick Ratio	1.93
Debt / Equity	n/a
Debt / EBITDA	n/a
Debt / FCF	n/a
Interest Coverage	-5.75

Financial Efficiency

Return on Equity (ROE)	n/a
Return on Assets (ROA)	-48.88%
Return on Capital (ROIC)	-61.30%
Revenue Per Employee	$391,664
Profits Per Employee	-$789,317
Employee Count	556
Asset Turnover	0.33
Inventory Turnover	n/a

Taxes

Income Tax	n/a
Effective Tax Rate	n/a

Stock Price Statistics

The stock price has decreased by -10.09% in the last 52 weeks. The beta is 1.05, so BBIO's price volatility has been similar to the market average.

Beta (5Y)	1.05
52-Week Price Change	-10.09%
50-Day Moving Average	27.49
200-Day Moving Average	26.71
Relative Strength Index (RSI)	68.27
Average Volume (20 Days)	2,642,615

Short Selling Information

The latest short interest is 19.30 million, so 10.21% of the outstanding shares have been sold short.

Short Interest	19.30M
Short Previous Month	17.12M
Short % of Shares Out	10.21%
Short % of Float	15.05%
Short Ratio (days to cover)	11.24

Income Statement

In the last 12 months, BBIO had revenue of $217.77 million and -$438.86 million in losses. Loss per share was -$2.41.

Revenue	217.77M
Gross Profit	215.37M
Operating Income	-516.20M
Pretax Income	-453.82M
Net Income	-438.86M
EBITDA	-509.90M
EBIT	-516.20M
Loss Per Share	-$2.41

Balance Sheet

The company has $266.32 million in cash and $1.73 billion in debt, giving a net cash position of -$1.46 billion or -$7.74 per share.

Cash & Cash Equivalents	266.32M
Total Debt	1.73B
Net Cash	-1.46B
Net Cash Per Share	-$7.74
Equity (Book Value)	-1.22B
Book Value Per Share	-6.51
Working Capital	305.36M

Cash Flow

In the last 12 months, operating cash flow was -$450.22 million and capital expenditures -$1.32 million, giving a free cash flow of -$451.54 million.

Operating Cash Flow	-450.22M
Capital Expenditures	-1.32M
Free Cash Flow	-451.54M
FCF Per Share	-$2.39

Margins

Gross margin is 98.90%, with operating and profit margins of -237.04% and -201.53%.

Gross Margin	98.90%
Operating Margin	-237.04%
Pretax Margin	-204.94%
Profit Margin	-201.53%
EBITDA Margin	-234.15%
EBIT Margin	-237.04%
FCF Margin	n/a

Dividends & Yields

BBIO does not appear to pay any dividends at this time.

Dividend Per Share	n/a
Dividend Yield	n/a
Dividend Growth (YoY)	n/a
Years of Dividend Growth	n/a
Payout Ratio	n/a
Buyback Yield	-16.50%
Shareholder Yield	-16.50%
Earnings Yield	-6.87%
FCF Yield	-7.07%

Analyst Forecast

The average price target for BBIO is $48.33, which is 43.03% higher than the current price. The consensus rating is "Strong Buy".

Price Target	$48.33
Price Target Difference	43.03%
Analyst Consensus	Strong Buy
Analyst Count	13
Revenue Growth Forecast (5Y)	152.92%
EPS Growth Forecast (5Y)	n/a

Stock Splits

This stock does not have any record of stock splits.

Last Split Date	n/a
Split Type	n/a
Split Ratio	n/a

Scores

BBIO has an Altman Z-Score of -5.96 and a Piotroski F-Score of 3. A Z-score under 3 suggests an increased risk of bankruptcy.

Altman Z-Score	-5.96
Piotroski F-Score	3